Synthesis and cytotoxic activity of certain trisubstituted azetidin-2-one derivatives as a cis-restricted combretastatin A-4 analogues
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Elmeligie S. | |
dc.contributor.author | Taher A.T. | |
dc.contributor.author | Khalil N.A. | |
dc.contributor.author | El-said A.H. | |
dc.contributor.other | Pharmaceutical Organic Chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Cairo University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Organic Chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | October University for Modern Sciences and Arts (MSA) | |
dc.contributor.other | 6th October City | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt; Pharmaceutical Organic Chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Misr University for Science and Technology | |
dc.contributor.other | 6th October City | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:41:28Z | |
dc.date.available | 2020-01-09T20:41:28Z | |
dc.date.issued | 2017 | |
dc.description | Scopus | |
dc.description.abstract | Novel series of 1,3,4-trisubstituted azetidin-2-one derivatives 8a�p were synthesized and proposed as cytotoxic agents acting via inhibition of tubulin at the colchicine binding site. The design of the target compounds was based upon modification in the structure of the vascular targeting agent combretastatin A-4 (CA-4). The cis double bond linker in CA-4 was replaced with the azetidin-2-one ring aiming to prevent the cis/trans isomerization that suppresses the activity of CA-4, thereby enhancing its antiproliferative activity. All new compounds were investigated in vitro against MCF-7 and HCT-116 cell lines. The inhibition of tubulin polymerization by four most potent compounds 8g, 8j, 8n and 8o was also evaluated. The synthesis of the final targets was achieved adopting Staudinger reaction. Molecular modeling studies were performed to rationalize the biological results. � 2016, The Pharmaceutical Society of Korea. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=19958&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/10.1007/s12272-016-0849-y | |
dc.identifier.doi | PubMed ID 27747473 | |
dc.identifier.issn | 2536269 | |
dc.identifier.other | https://doi.org/10.1007/s12272-016-0849-y | |
dc.identifier.other | PubMed ID 27747473 | |
dc.identifier.uri | https://t.ly/1VwlB | |
dc.language.iso | English | en_US |
dc.publisher | Pharmaceutical Society of Korea | en_US |
dc.relation.ispartofseries | Archives of Pharmacal Research | |
dc.relation.ispartofseries | 40 | |
dc.subject | October University for Modern Sciences and Arts | |
dc.subject | جامعة أكتوبر للعلوم الحديثة والآداب | |
dc.subject | University of Modern Sciences and Arts | |
dc.subject | MSA University | |
dc.subject | Azetidin-2-one | en_US |
dc.subject | Combretastatin A4 | en_US |
dc.subject | Cytotoxic activity | en_US |
dc.subject | Tubulin | en_US |
dc.subject | 3 chloro 4 (4 chlorophenyl) 1 (4 methoxyphenyl) 3 methyl azetidin 2 one | en_US |
dc.subject | 3 chloro 4 (furan 2 yl) 1 (4 methoxyphenyl)azetidin 2 one | en_US |
dc.subject | 4 (2 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 one | en_US |
dc.subject | 4 (2 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 one | en_US |
dc.subject | 4 (2 bromophenyl) 3 chloro 1 (3,4,5 trimethoxyphenyl) 3 methylazetidin 2 one | en_US |
dc.subject | 4 (2 bromophenyl) 3 chloro 1 (3,4,5 trimethoxyphenyl)azetidin 2 one | en_US |
dc.subject | 4 (2 bromophenyl) 3 chloro 1 (4 methoxyphenyl) 3 methylazetidin 2 one | en_US |
dc.subject | 4 (2 bromophenyl) 3 chloro 1 (4 methoxyphenyl)azetidin 2 one | en_US |
dc.subject | 4 (3 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 one | en_US |
dc.subject | 4 (3,4,5 trimethoxyphenyl) 1 (4 methoxyphenyl) 3 (2 thienyl)azetidin 2 one | en_US |
dc.subject | 4 (4 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 one | en_US |
dc.subject | 4 (4 bromophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 one | en_US |
dc.subject | 4 (4 bromophenyl) 3 chloro 1 (4 methoxyphenyl)azetidin 2 one | en_US |
dc.subject | 4 (4 chlorophenyl) 1 (3,4,5 trimethoxyphenyl) 3 (2 thienyl)azetidin 2 one | en_US |
dc.subject | 4 (4 chlorophenyl) 1 (3,4,5 trimethoxyphenyl) 3 phenylazetidin 2 one | en_US |
dc.subject | 4 (4 chlorophenyl) 1 (4 methoxyphenyl) 3 (2 theinyl)azetidin 2 one | en_US |
dc.subject | azetidin 2 one derivative | en_US |
dc.subject | azetidine derivative | en_US |
dc.subject | colchicine | en_US |
dc.subject | combretastatin A4 | en_US |
dc.subject | cytotoxic agent | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | azetidine | en_US |
dc.subject | azetidine derivative | en_US |
dc.subject | bibenzyl derivative | en_US |
dc.subject | combretastatin | en_US |
dc.subject | cytotoxin | en_US |
dc.subject | antiproliferative activity | en_US |
dc.subject | Article | en_US |
dc.subject | cytotoxicity | en_US |
dc.subject | drug binding site | en_US |
dc.subject | drug design | en_US |
dc.subject | drug structure | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | HCT 116 cell line | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | in vitro study | en_US |
dc.subject | isomerization | en_US |
dc.subject | MCF-7 cell line | en_US |
dc.subject | microtubule assembly | en_US |
dc.subject | molecular model | en_US |
dc.subject | Staudinger reaction | en_US |
dc.subject | structure activity relation | en_US |
dc.subject | cell survival | en_US |
dc.subject | drug effects | en_US |
dc.subject | physiology | en_US |
dc.subject | synthesis | en_US |
dc.subject | Azetidines | en_US |
dc.subject | Bibenzyls | en_US |
dc.subject | Cell Survival | en_US |
dc.subject | Cytotoxins | en_US |
dc.subject | HCT116 Cells | en_US |
dc.subject | Humans | en_US |
dc.subject | MCF-7 Cells | en_US |
dc.title | Synthesis and cytotoxic activity of certain trisubstituted azetidin-2-one derivatives as a cis-restricted combretastatin A-4 analogues | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Al-Tai, A.S., Hall, D.M., Mears, A.R., Nuclear magnetic resonance spectra of azomethines. Part I. Benzylideneanilines (1976) J Chem Soc, Perkin Trans, 2, pp. 133-136; Andreu, J.M., Perez-Ramirez, B., Gorbunoff, M.J., Ayala, D., Timasheff, S.N., Role of the colchicine ring A and its methoxy groups in the binding to tubulin and microtubule inhibition (1998) Biochemistry, 37, pp. 8356-8368. , COI: 1:CAS:528:DyaK1cXjtlWltLk%3D, PID: 9622487; Bandyopadhyay, D., Banik, B.K., Microwave-induced stereocontrol of ?-lactam formation with an N-benzylidene-9, 10-dihydrophenanthren-3-amine via Staudinger cycloaddition (2010) Helv Chim Acta, 93, pp. 298-301. , COI: 1:CAS:528:DC%2BC3cXitV2nsL0%3D; Bose, A.K., Banik, B.K., Manhas, M.S., Stereocontrol of ?-lactam formation using microwave irradiation (1995) Tetrahedron Lett, 36, pp. 213-216. , COI: 1:CAS:528:DyaK2MXjtlegt7c%3D; Banik, I., Becker, F.F., Banik, B.K., Stereoselective synthesis of ?-lactams with polyaromatic imines: entry to new and novel anticancer agents (2003) J Med Chem, 46, pp. 12-15. , COI: 1:CAS:528:DC%2BD38XptVagtr8%3D, PID: 12502355; Banik, B.K., Banik, I., Becker, F.F., Stereocontrolled synthesis of anticancer beta-lactams via the Staudinger reaction (2005) Bioorg Med Chem, 13, pp. 3611-3622. , COI: 1:CAS:528:DC%2BD2MXjvVKltrk%3D, PID: 15862989; Cragg, G.M., Newman, D.J., Plants as a source of anti-cancer agents (2005) J Ethnopharmacol, 100, pp. 72-79. , COI: 1:CAS:528:DC%2BD2MXmvVKnsLY%3D, PID: 16009521; Downing, K.H., Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics 1 (2000) Annu Rev Cell Dev Biol, 16, pp. 89-111. , COI: 1:CAS:528:DC%2BD3MXpvFOg, PID: 11031231; Dumontet, C., Jordan, M.A., Microtubule-binding agents: a dynamic field of cancer therapeutics (2010) Nat Rev Drug Discov, 9, pp. 790-803. , COI: 1:CAS:528:DC%2BC3cXht1akur%2FI, PID: 20885410; Dorleans, A., Gigant, B., Ravelli, R.B., Mailliet, P., Mikol, V., Knossow, M., Variations in the colchicine-binding domain provide insight into the structural switch of tubulin (2009) Proc Natl Acad Sci USA, 106, pp. 13775-13779. , COI: 1:CAS:528:DC%2BD1MXhtFWksLrO, PID: 19666559; Greene, T.F., Wang, S., Greene, L.M., Nathwani, S.M., Pollock, J.K., Malebari, A.M., Mccabe, T., Meegan, M.J., Synthesis and biochemical evaluation of 3-phenoxy-1,4-diarylazetidin-2-ones as tubulin-targeting antitumor agents (2016) J Med Chem, 59, pp. 90-113. , COI: 1:CAS:528:DC%2BC2MXhvFGnsr7L, PID: 26680364; Jordan, M., Mechanism of action of antitumor drugs that interact with microtubules and tubulin (2002) Curr Med Chem-Anti-Cancer Agents, 2, pp. 1-17. , COI: 1:CAS:528:DC%2BD38XislGmurg%3D; Klimczak, A.A., Kuropatwa, A., Lewkowski, J., Szemraj, J., Synthesis of new N-arylamino(2-furyl)methylphosphonic acid diesters, and in vitro evaluation of their cytotoxicity against esophageal cancer cells (2012) Med Chem Res, 22, pp. 852-860; Lippert, J.W., 3rd, Vascular disrupting agents (2007) Bioorg Med Chem, 15, pp. 605-615. , COI: 1:CAS:528:DC%2BD28XhtleisL7E, PID: 17070061; O�boyle, N.M., Carr, M., Greene, L.M., Bergin, O., Nathwani, S.M., Mccabe, T., Lloyd, D.G., Meegan, M.J., Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents (2010) J Med Chem, 53, pp. 8569-8584. , PID: 21080725; O�boyle, N.M., Carr, M., Greene, L.M., Keely, N.O., Knox, A.J., Mccabe, T., Lloyd, D.G., Meegan, M.J., Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe (2011) Eur J Med Chem, 46, pp. 4595-4607. , PID: 21840628; O�boyle, N.M., Greene, L.M., Bergin, O., Fichet, J.-B., Mccabe, T., Lloyd, D.G., Zisterer, D.M., Meegan, M.J., Synthesis, evaluation and structural studies of antiproliferative tubulin-targeting azetidin-2-ones (2011) Bioorg Med Chem, 19, pp. 2306-2325. , PID: 21397510; Ohsumi, K., Hatanaka, T., Fujita, K., Nakagawa, R., Fukuda, Y., Nihei, Y., Suga, Y., Tsuji, T., Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues (1998) Bioorg Med Chem Lett, 8, pp. 3153-3158. , COI: 1:CAS:528:DyaK1MXht1Kl, PID: 9873694; Skehan, P., Storeng, R., Scudiero, D., Monks, A., Mcmahon, J., Vistica, D., Warren, J.T., Boyd, M.R., New colorimetric cytotoxicity assay for anticancer-drug screening (1990) J Natl Cancer Inst, 82, pp. 1107-1112. , COI: 1:CAS:528:DyaK3cXltVylsL8%3D, PID: 2359136; Suresh, R., Kamalakkannan, D., Ranganathan, K., Arulkumaran, R., Sundararajan, R., Sakthinathan, S., Vijayakumar, S., Vanangamudi, G., Solvent-free synthesis, spectral correlations and antimicrobial activities of some aryl imines (2013) Spectrochimica Acta Part A, 101, pp. 239-248. , COI: 1:CAS:528:DC%2BC38XhslCjs7rE; Tozer, G.M., Prise, V.E., Wilson, J., Locke, R.J., Vojnovic, B., Stratford, M.R., Dennis, M.F., Chaplin, D.J., Combretastatin A-4 phosphate as a tumor vascular-targeting agent early effects in tumors and normal tissues (1999) Cancer Res, 59, pp. 1626-1634. , COI: 1:CAS:528:DyaK1MXisVWku7s%3D, PID: 10197639; Wang, L., Woods, K.W., Li, Q., Barr, K.J., Mccroskey, R.W., Hannick, S.M., Gherke, L., Marsh, K., Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation (2002) J Med Chem, 45, pp. 1697-1711. , COI: 1:CAS:528:DC%2BD38XhslOgtbc%3D, PID: 11931625; Wei, W., Ayad, N.G., Wan, Y., Zhang, G.J., Kirschner, M.W., Kaelin, W.G., Jr., Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex (2004) Nature, 428, pp. 194-198. , COI: 1:CAS:528:DC%2BD2cXhvFCls70%3D, PID: 15014503; West, C.M., Price, P., Combretastatin A4 phosphate (2004) Anticancer Drugs, 15, pp. 179-187. , COI: 1:CAS:528:DC%2BD2cXjslWqtL8%3D, PID: 15014350; Xu, J., Stereoselectivity in the synthesis of 2-azetidinones from ketenes and imines via the Staudinger reaction (2009) Arkivoc, 9, pp. 21-44 | |
dcterms.source | Scopus |